| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |